La presente informativa è resa, anche ai sensi dell’art. 13 del D. Lgs. 196/2003 “Codice in materia di protezione dei dati personali” (“Codice Privacy”) 
e degli artt. 13 e 14 del Regolamento (UE) 2016/679 (“GDPR”), a coloro che si collegano alla presente edizione online del giornale Tribuna Economica di proprietà di AFC Editore Soc. Coop. 

Leggi di più



The European Investment Bank and Afreximbank have joined forces to enhance healthcare and pharmaceutical investment across sub-Saharan Africa and strengthen health resilience on the continent. The new EUR 200 million health investment initiative was formally launched by EIB Vice President Thomas Östros and Afreximbank

Executive Vice President Denys Denya at the 5th United Nations Conference on Least Developed Countries taking place in Doha, Qatar.

Afreximbank and the European Investment Bank will each provide EUR 100 million new investment to update and expand public healthcare facilities and enhance production of safe, affordable and effective medicines across sub-Saharan Africa. This is EIB’s first dedicated backing for intermediated health investment in Africa,

The new Africa health financing initiative, part of the European Union Global Gateway initiative, has been designed by health, financial and technical experts from EIB and Afreximbank to unlock crucial investment to improve access to local healthcare and scale-up production of medicines essential to tackle deadly diseases such as cancer, HIV, malaria and tuberculosis.

Improving access to healthcare across Africa.        Rapid expansion of affordable public healthcare is crucial to improve public health in Africa. The new EIB-Afreximbank initiative will support new investment in health facilities, including construction and equipment of clinicals and hospitals, essential to enable rapid treatment of communicable diseases, reduce infant mortality and facilitate accessibility to public healthcare.

Supporting investment to expand local pharmaceutical production.      At present only a few countries in sub-Saharan Africa host pharmaceutical production companies. The new health resilience investment initiative will also target financing to scale up local production of quality pharmaceuticals in sub-Saharan Africa. This will help to address the chronic shortage of essential medicines needed to combat cancer, HIV, malaria and tuberculosis as well as improve medical care for new-born infants and mothers.

Since the start of the COVID pandemic, the European Investment Bank has provided more than EUR 12 billion for health investment around the world, including support for vaccine development, production and distribution, upgrading hospitals and improving medical education. In recent years, the EIB has supported health and healthcare investment in Angola, Benin, Ghana, Morocco and Niger alongside supporting the COVAX Covid vaccine initiative across Africa.

Afreximbank spearheaded Africa’s effective response to the COVID pandemic by financing the Africa Medical Supplies Platform (AMSP) that enabled pooled procurement of PPEs, and providing 2 billion dollars to procure and distribute vaccines under the acclaimed AVAT program.